Increased natural killer cells and decreased CD3+CD8+CD62L+ T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib-Reference-Cited by-同舟云学术

Increased natural killer cells and decreased CD3+CD8+CD62L+ T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib

Published:2011-11-11 Issue:2 Volume:157 Page:254-256
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Ohyashiki Kazuma,Katagiri Sei-ichiro,Tauchi Tetsuzo,Ohyashiki Junko H,Maeda Yasuhiro,Matsumura Itaru,Kyo Tai-ichi

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08939.x/fullpdf

Reference7 articles.

1. Hematology: curing CML with imatinib - a dream come true?;Deininger;Nature Review in Oncology,2011

2. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial;Mahon;Lancet Oncology,2010

3. Clonal expansion of T-NK-cells during tyrosine kinase inhibitor dasatinib therapy;Mustjoki;Leukemia,2009

4. Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy;Rohon;European Journal of Haematology,2010

5. Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR;Ross;Leukemia,2010

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational modeling reveals key factors driving treatment-free remission in chronic myeloid leukemia patients;npj Systems Biology and Applications;2024-04-27

2. Tyrosine Kinase Inhibitors Do Not Promote a Decrease in SARS-CoV-2 Anti-Spike IgG after BNT162b2 Vaccination in Chronic Myeloid Leukemia: A Prospective Observational Study;Vaccines;2022-08-27

3. Mechanism of treatment-free remission in patients with chronic myeloid leukemia revealed by a computational model of CML evolution;2022-05-21

4. A Gut Instinct on Leukaemia: A New Mechanistic Hypothesis for Microbiota-Immune Crosstalk in Disease Progression and Relapse;Microorganisms;2022-03-25

5. Treatment-Free Remission—A New Aim in the Treatment of Chronic Myeloid Leukemia;Journal of Personalized Medicine;2021-07-22